Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shazzle
    Junior Member
    • Mar 2010
    • 3

    #1

    RNAi questions from a bioinformatician

    Hi guys,

    I have a few questions. Pardon me if I sound as if I'm just starting out in RNAi studies (which I am ).

    1. Is there a consensus that miRNA will only bind to the 3' UTR region only for interference, and does siRNA and shRNA exhibit the same action of binding to 3' UTR for interference?

    2. If 1. is true, can miRNA and si/shRNA bind to other regions besides the 3' UTR and also degrades/inhibits the mRNA?

    3. For off-target effects, can the un-intended target become degraded as a result of the off-target binding?

    Thanks!
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    You really should find a good, recent & in depth review of the subject (try Reviews in... or Nature Reviews) for your first 2; I've been out of the field too long to answer those. It may also not be a question of absolutes but efficiency; certain locations in the mRNA may be more efficient than others.

    Your #3 is the major mode of off-target effects nowadays (if experiments are performed correctly).

    More generic off-target effects can come from either (a) overloading the processing machinery or (b) triggering an anti-viral response. Both are controlled by minimizing the dose of siRNA.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...